State Street Corporation has appointed healthcare product producer Covidien chairman José (Joe) E. Almeida to its board of directors.
With more than 18 years leadership experience at the large public company, Almeida will bring a valuable knowledge of innovation and competition to the financial services research group, Joseph L. Hooley, chairman, president and chief executive officer of State Street Corporation, said.
Almeida joined Covidien in 1995 and has served as chairman of the company's board of directors since March 2012.
He has also previously held senior roles at Greatbatch Technologies, Inc., American Home Products' Acufex Microsurgical division and Johnson & Johnson's professional products division.
Almeida is also on the board of directors at Advanced Medical Technology Association (AdvaMed) and Partners in Health.
Blue Owl Capital, a US asset manager with its eye on ‘marquee investors’ like super funds, has announced the appointment of a senior Future Fund executive as its newest managing director.
The Association of Superannuation Funds of Australia has appointed a new director representing industry funds, among a number of other appointments in recent months.
The Association of Superannuation Funds of Australia has tapped an experienced public policy executive as head of policy and advocacy.
The firm has welcomed an experienced financial services executive, who helped establish Vanguard's superannuation business, as its new chief financial officer.
Add new comment